Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
First Trust Alternative Absolute Return Strategy ETF
FAAR
$196M
| $495K | ﹤0.01% |
17,119
-3,153
| -16% | -$89.8K |
|
3927
Live Oak Bancshares
LOB
$2B
| $495K | ﹤0.01% |
18,592
+4,146
| +29% | +$138K |
|
|
SAND
3928
DELISTED
Sandstorm Gold
SAND
| $494K | ﹤0.01% |
65,526
+7,189
| +12% | +$44.9K |
|
3929
Pliant Therapeutics
PLRX
$66.3M
| $491K | ﹤0.01% |
362,702
+250,185
| +222% | +$1.52M |
|
3930
Sabre
SABR
$900M
| $491K | ﹤0.01% |
174,893
+55,840
| +47% | +$198K |
|
3931
XPeng
XPEV
$11.2B
| $490K | ﹤0.01% |
23,657
+5,945
| +34% | +$107K |
|
3932
Amer Sports
AS
$19.1B
| $490K | ﹤0.01% |
18,336
-3,938
| -18% | -$116K |
|
3933
Putnam Focused Large Cap Growth ETF
PGRO
$215M
| $489K | ﹤0.01% |
+14,115
| New | +$536K |
|
3934
Stratasys
SSYS
$781M
| $488K | ﹤0.01% |
49,921
-49,144
| -50% | -$505K |
|
|
GDEN
3935
DELISTED
Golden Entertainment
GDEN
| $487K | ﹤0.01% |
18,426
-14,597
| -44% | -$449K |
|
3936
Regional Management Corp
RM
$309M
| $487K | ﹤0.01% |
16,200
+375
| +2% | +$12.6K |
|
3937
Riskified
RSKD
$875M
| $487K | ﹤0.01% |
105,379
-223
| -0.2% | -$1.12K |
|
3938
S&T Bancorp
STBA
$1.8B
| $487K | ﹤0.01% |
13,147
+1,206
| +10% | +$46.3K |
|
3939
Fidelity Enhanced International ETF
FENI
$11.4B
| $486K | ﹤0.01% |
16,340
+12,733
| +353% | +$375K |
|
3940
BlackRock MuniYield Quality Fund
MQY
$812M
| $486K | ﹤0.01% |
41,532
-3,064
| -7% | -$36.3K |
|
|
ETNB
3941
DELISTED
89bio
ETNB
| $484K | ﹤0.01% |
66,688
-46,362
| -41% | -$405K |
|
3942
Parke Bancorp
PKBK
$413M
| $484K | ﹤0.01% |
25,663
-3,587
| -12% | -$69.7K |
|
3943
State Street SPDR Dow Jones International Real Estate ETF
RWX
$266M
| $483K | ﹤0.01% |
19,782
-289
| -1% | -$6.91K |
|
3944
Invesco RAFI Strategic US ETF
IUS
$958M
| $482K | ﹤0.01% |
9,761
-757
| -7% | -$38.2K |
|
3945
Protagonist Therapeutics
PTGX
$10B
| $482K | ﹤0.01% |
9,964
+2,334
| +31% | +$97.8K |
|
3946
Sabesp
SBS
$16.2B
| $482K | ﹤0.01% |
138,979
-3,594
| -3% | -$11.4K |
|
3947
Five Point Holdings
FPH
$371M
| $481K | ﹤0.01% |
89,847
+35,818
| +66% | +$189K |
|
3948
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.23B
| $480K | ﹤0.01% |
18,112
+2,171
| +14% | +$56.6K |
|
|
KE
3949
Kimball Electronics
KE
$622M
| $480K | ﹤0.01% |
29,199
+1,588
| +6% | +$28.1K |
|
|
GOLD
3950
Gold.com Inc
GOLD
$1.28B
| $479K | ﹤0.01% |
18,865
-967
| -5% | -$26.8K |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.